Download:
pdf |
pdfATTACHMENT E:
IRB APPROVALS
ATTACHMENT E - 1:
APPROVAL LETTER FROM THE NCI SPECIAL STUDIES INSTITUTIONAL
REVIEW BOARD
Department of Health & Human Services
Public Health Service
National Institutes of Health
National Cancer Institute
Bethesda, Maryland 20892
iRIS Reference Number 327123
Type of Action: Submission Response for Initial Review Submission Form
Project Number: P131259
05/30/2013
TO:
Linda Nebeling
NCI - Division of Cancer Control and Population Sciences
FROM:
Chairperson, Special Studies Institutional Review Board, NCI
SUBJECT:
Action on Clinical Research Protocol
The Initial Review of your protocol and consent document, “Family Life, Activity, Sun, Health and Eating
Study,” was reviewed by the National Cancer Institute Special Studies Institutional Review Board (NCI-SSIRB)
by full board review on 04/15/2013.
The IRB has taken the following action:
X
Approved as written. Forwarded to the CC OPS for administrative processing.
Approved with stipulations pending re-review by SSIRB Chair. See review.
Approved with stipulations pending re-review by a subcommittee of the Board. See
review.
Deferred pending response to stipulations and re-review by the full SSIRB. See review.
Disapproved. See review.
ATTACHMENT E - 2:
APPROVAL LETTERS FROM THE WESTAT INSTITUTIONAL REVIEW
BOARD
Date:
March 14th, 2013
To:
Terisa David, Project Director
From:
Kerry Levin, Chair Westat IRB
Subject:
Expedited Approval of FLASHE, Project 6053.01.01
FWA 00005551
As Chair of the Westat Institutional Review Board (IRB), I reviewed the materials submitted for the following:
FLASHE, Project 6053.01.01. The Westat IRB reviews all studies involving research on human subjects. This
study is funded by National Cancer Institute.
The purpose of this study is to assess how daily lifestyle practices may affect the health of parents and their teenage
children. Parents and children will each complete two on-line surveys, one about physical activity and the other will
be about eating habits. In addition, some teenagers will be asked to participate in a part of the study that will
measure physical activity levels. If selected, teens will wear a wrist accelerometer (a monitor that records body
movement) for seven days in a row and fill out log recordings.
Gift cards ($5) will be provided for teens and their parents who complete each online survey. Additional gift cards
($20/$40) will be provided for participation in the motion sensing study.
Per 45 CFR 46, IRB regulations permit expedited review of certain activities involving minimal risk [45 CFR pt.
46.110 (b) 1 and 404]. This study was considered minimal risk and approved under expedited authority. Because
obtaining consent from only one parent does not adversely affect the rights and welfare of the subjects, and that the
research may not practicably be carried out without the waiver, the IRB also approved the request to waive
permission of one parent or guardian [45 CFR 46.116 of Subpart A and 46.408 (b)]. Further, Per 45 CFR 46 117(c),
documentation of informed consent is also approved for parent consent as the research presents no more than
minimal risk of harm to subjects and involves no procedures for which written consent is normally required outside
of the research context.
As the Project Director you are responsible for the following:
cc:
You are required to submit this study for a continuing review on or before March 14, 2014.
In the interim, you are responsible for notifying the IRB Office as soon as possible if there are any injuries
to the subjects, problems with the study, or changes to the study design that relate to human subjects.
Institutional Review Board
Nancy Weinfield
Date:
May 31st, 2013
To:
Terisa Davis, Project Director
From:
Kerry Levin, Chair Westat IRB
Subject:
Expedited Amendment Approval of FLASHE, Project 6053.01.01
FWA 00005551
As Chair of the Westat Institutional Review Board (IRB), I reviewed the materials submitted for the following:
FLASHE, Project 6053.01.01. The Westat IRB reviews all studies involving research on human subjects. This
study is funded by National Cancer Institute. The study was last reviewed on March 14, 2013.
This request is to approve an amendment to a previously approved protocol due to stipulations made by the
National Cancer Institute IRB.
The regulations (45 CFR 46) permit expedited review of minor changes to previously approved activities. I am
therefore approving the modifications under expedited authority. This study can be considered minimal risk and is
approved under expedited authority.
As the Project Director you are responsible for the following:
cc:
You are required to submit this study for a continuing review on or before March 14, 2014.
In the interim, you are responsible for notifying the IRB Office as soon as possible if there are any injuries
to the subjects, problems with the study, or changes to the study design that relate to human subjects.
Institutional Review Board
Nancy Weinfield
File Type | application/pdf |
Author | Terisa Davis |
File Modified | 2013-08-27 |
File Created | 2013-06-10 |